# OnCo record foghorn-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/foghorn-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "foghorn-therapeutics" ;
  schema:name "Foghorn Therapeutics"@en ;
  schema:description "Foghorn Therapeutics makes drugs that act on the machinery that packages DNA and controls which genes are switched on. Its lead drug, partnered with Lilly, targets lung cancers that have lost a gene called SMARCA4."@en ;
  schema:url <https://onco.cc/companies/foghorn-therapeutics/>, <https://www.foghorntx.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.foghorntx.com/>, <https://www.foghorntx.com/pipeline/>, <https://www.sec.gov/Archives/edgar/data/1822462/000119312520310711/d98800dex991.htm> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:sections <https://onco.cc/fronts/epigenetics/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/>, <https://onco.cc/technologies/epigenetic-drugs/>, <https://onco.cc/technologies/synthetic-lethality-approaches/> .
